Publication | Closed Access

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302

Radiation MedicineRadiation TherapyMedicineRadionuclide TherapyCancer TreatmentRadiation OncologyOncologyGliomaGy B.i.dTreatment VerificationBis-chlorethyl NitrosoureaRadiologyHealth Sciences